[en] Pleomorphic adenoma gene (PLAG) 1, the main translocation target in pleomorphic adenomas of the salivary glands, is a member of a new subfamily of zinc finger proteins comprising the tumor suppressor candidate PLAG-like1 (also called ZAC1 or lost on transformation 1) and PLAGL2. In this report, we show that NIH3T3 cells overexpressing PLAG1 or PLAGL2 display the typical markers of neoplastic transformation: (a) the cells lose cell-cell contact inhibition; (b) show anchorage-independent growth; and (c) are able to induce tumors in nude mice. In contrast, PLAGL1 has been shown to prevent the proliferation of tumor cells by inducing cell cycle arrest and apoptosis. This difference in function is also reflected in their DNA binding, as we show here that the three PLAG proteins, although highly homologous in their DNA-binding domain, bind different DNA sequences in a distinct fashion. Interestingly, the PLAG1- and PLAGL2-induced transformation is accompanied by a drastic up-regulation of insulin-like growth factor-II, which we prove is a target of PLAG1 and PLAGL2. This strongly suggests that the oncogenic capacity of PLAG1 and PLAGL2 is mediated at least partly by activating the insulin-like growth factor-II mitogenic pathway.
Research center :
Giga-Development and Stem Cells - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Hensen, Karen; Katholieke Universiteit Leuven - KUL > Center for Human Genetics > Laboratory for Molecular Oncology
Van Valckenborgh, Isabelle C C
Kas, Koen
Van de Ven, Wim J M
Voz, Marianne ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Language :
English
Title :
The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.
Publication date :
01 March 2002
Journal title :
Cancer Research
ISSN :
0008-5472
eISSN :
1538-7445
Publisher :
American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland
Kas K., Voz M.L., Roijer E., Astrom A.K., Meyen E., Stenman G., Van de Ven W.J. (1997) Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat. Genet. 15:170-174.
Voz M.L., Astrom A.K., Kas K., Mark J., Stenman G., Van de Ven W.J. (1998) The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene 16:1409-1416.
Astrom A.K., Voz M.L., Kas K., Roijer E., Wedell B., Mandahl N., Van de Ven W., Mark J., Stenman G. (1999) Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: Identification of SII as a new fusion partner gene. Cancer Res. 59:918-923.
Voz M.L., Agten N.S., Van de Ven W.J., Kas K. (2000) PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res. 60:106-113.
Kas K., Voz M.L., Hensen K., Meyen E., Van de Ven W.J.M. (1998) Transcriptional activation capacity of the novel PLAG family of zinc finger proteins. J. Biol. Chem. 273:23026-23032.
Abdollahi A., Roberts D., Godwin A.K., Schultz D.C., Sonoda G., Testa J.R., Hamilton T.C. (1997) Identification of a zinc-finger gene at 6q25: A chromosomal region implicated in development of many solid tumors. Oncogene 14:1973-1979.
Spengler D., Villalba M., Hoffmann A., Pantaloni C., Houssami S., Bockaert J., Journot L. (1997) Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 16:2814-2825.
Varrault A., Ciani E., Apiou F., Bilanges B., Hoffmann A., Pantaloni C., Bockaert J., Spengler D., Journot L. (1998) hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc. Natl. Acad. Sci. USA 95:8835-8840.
Bilanges B., Varrault A., Basyuk E., Rodriguez C., Mazumdar A., Pantaloni C., Bockaert J., Theillet C., Spengler D., Journot L. (1999) Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 18:3979-3988.
Hawley R.G., Lieu F.H., Fong A.Z., Hawley T.S. (1994) Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
Morin P.J., Vogelstein B., Kinzler K.W. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA 93:7950-7954.
Nordeen S.K. (1988) Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454-458.
Chomczynski P., Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
Dull T.J., Gray A., Hayflick J.S., Ullrich A. (1984) Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature (Lond.) 310:777-781.
Sanchez M.P., Silos-Santiago I., Frisen J., He B., Lira S.A., Barbacid M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature (Lond.) 382:70-73.
Ikeda K., Kawakami K. (1995) DNA binding through distinct domains of zinc-fingerhomeodomain protein AREB6 has different effects on gene transcription. Eur. J. Biochem. 233:73-82.
Jainchill J.L., Aaronson S.A., Todaro G.J. (1969) Murine sarcoma and leukemia viruses: Assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4:549-553.
Seth A., Papas T.S. (1990) The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated. Oncogene 5:1761-1767.
Abdollahi A., Bao R., Hamilton T.C. (1999) LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene 18:6477-6487.
Hibbard M.K., Kozakewich H.P., Dal Cin P., Sciot R., Tan X., Xiao S., Fletcher J.A. (2000) PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 60:4869-4872.
Toretsky J.A., Helman L.J. (1996) Involvement of IGF-II in human cancer. J. Endocrinol. 149:367-372.
Roberts C.T. Jr., Brown A.L., Graham D.E., Seelig S., Berry S., Gabbay K.H., Rechler M.M. (1986) Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver. J. Biol. Chem. 261:10025-10028.
Brown A.L., Graham D.E., Nissley S.P., Hill D.J., Strain A.J., Rechler M.M. (1986) Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J. Biol. Chem. 261:13144-13150.
LeRoith D., Werner H., Neuenschwander S., Kalebic T., Helman L.J. (1995) The role of the insulin-like growth factor-I receptor in cancer. Ann. N. Y. Acad. Sci. 766:402-408.
Sell C., Dumenil G., Deveaud C., Miura M., Coppola D., DeAngelis T., Rubin R., Efstratiadis A., Baserga R. (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604-3612.
Sell C., Rubini M., Rubin R., Liu J.P., Efstratiadis A., Baserga R. (1993) Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 90:11217-11221.
Debiec-Rychter M., Van Valckenborgh I., Van Den Broeck C., Hagemeijer A., Van De Ven W.J., Kas K., Van Damme B., Voz M.L. (2001) Histologic localization of plag1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: Cytogenetic evidence of common origin of phenotypically diverse cells. Lab. Investig. 81:1289-1297.
Rodriguez-Tarduchy G., Collins M.K., Garcia I., Lopez-Rivas A. (1992) Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J. Immunol. 149:535-540.
Resnicoff M., Burgaud J.L., Rotman H.L., Abraham D., Baserga R. (1995) Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res. 55:3739-3741.
Choo Y., Klug A. (1997) Physical basis of a protein-DNA recognition code. Curr. Opin. Struct. Biol. 7:117-125.
Queimado L., Lopes C., Du F., Martins C., Bowcock A.M., Soares J., Lovett M. (1999) Pleomorphic adenoma gene I is expressed in cultured benign and malignant salivary gland tumor cells. Lab. Investig. 79:583-589.
Menke A.L., Riteco N., Van Ham R.C., De Bruyne C., Rauscher F.J.D., Van der Eb A.J., Jochemsen A.G. (1996) Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene 12:537-546.
Jiang G.L., Huang S. (2000) The yin-yang of PR-domain family genes in tumorigenesis. Histol. Histopathol. 15:109-117.
